Common Contracts
3 similar Share Purchase Agreement contracts by Xenon Pharmaceuticals Inc.
SHARE PURCHASE AGREEMENTShare Purchase Agreement • January 12th, 2022 • Xenon Pharmaceuticals Inc. • Pharmaceutical preparations • New York
This Share Purchase Agreement (this “Agreement”), is made as of January 11, 2022 (the “Signing Date”), by and between Neurocrine Biosciences, Inc. (the “Investor”), a Delaware corporation, and Xenon Pharmaceuticals Inc. (the “Company”), a Canadian corporation.
SHARE PURCHASE AGREEMENTShare Purchase Agreement • September 8th, 2021 • Xenon Pharmaceuticals Inc. • Pharmaceutical preparations • New York
This Share Purchase Agreement (this “Agreement”), is made as of September 8, 2021 (the “Signing Date”), by and between Neurocrine Biosciences, Inc. (the “Investor”), a Delaware corporation, and Xenon Pharmaceuticals Inc. (the “Company”), a Canadian corporation.
SHARE PURCHASE AGREEMENTShare Purchase Agreement • December 2nd, 2019 • Xenon Pharmaceuticals Inc. • Pharmaceutical preparations • New York
This Share Purchase Agreement (this “Agreement”), is made as of December 2, 2019 (the “Signing Date”), by and between Neurocrine Biosciences, Inc. (the “Investor”), a Delaware corporation, and Xenon Pharmaceuticals Inc. (the “Company”), a Canadian corporation.
